
arstechnica.com
The FDA wants to pull its approval of a drug. It’s not so easy.
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
This site doesn’t allow embedding inside another page — open it in a new tab. Your Weird rating still works from the top bar.
Open source